Welcome to PsychU!

Schizophrenia Treatment Goals & Shared Decision Making: A Practice-Based Learning Webinar

Loading Events

Thank You For Attending Today’s Webinar

Please tell us what you thought about today’s presentation by taking the survey below:

Schizophrenia Treatment Goals & Shared Decision Making: A Practice-Based Learning Webinar

Join Dr. Correll and Dr. Schooler for a discussion on how to engage patients in their own treatment decisions, help them define their treatment goals, and address treatment barriers that are often associated with schizophrenia. Together, they will lead an engaging practice-based learning session designed to both teach shared decision-making strategies and then demonstrate how they put them into practice.

Featuring

Christoph-Correll

Christoph Correll, MD

Chair of the Department of Child and Adolescent Psychiatry, Psychosomatic Medicine and Psychotherapy, Charité Universitätsmedizin Berlin, Campus Virchow, Berlin, Germany. Professor of Psychiatry at The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, USA.

More
Professor Correll’s research and clinical work focus on the identification, characterization and treatment of youth with severe mental illness, including psychotic and mood disorders, spanning all disease stages from the prodrome to first and multi-episode illness and up to refractory illness. He further focuses on psychopharmacology, epidemiology, comparative effectiveness, meta-analyses, the risk–benefit evaluation of psychotropic medications, and the interface between physical health and mental health.
Nina R.-Schooler

Nina R. Schooler, PhD

Professor of Psychiatry and Behavioral Sciences; State University of New York Downstate Medical Center

More
Professor Schooler’s research focuses on treatment of psychosis and schizophrenia from its earliest identification to long-term course and outcomes. Her expertise spans both pharmacologic and psychosocial interventions. Other areas of research focus on tardive dyskinesia and the systematic assessments of side effects, assessment and treatment of negative symptoms and assessment of social and vocational function measures as key to understanding long-term outcomes for schizophrenia and psychosis. Most recently her work has turned to integrating measurement-based care into treatment programs for first episode psychosis.
Linzy-Hendrickson

Linzy Hendrickson, PhD (OPDC)

Sr. Clinical & Scientific Liaison

Speakers Christoph Correll, MD and Nina R. Schooler, PhD are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.
Speaker Linzy Hendrickson, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Related Resources